Page last updated: 2024-08-25

methotrexate and Genetic Diseases

methotrexate has been researched along with Genetic Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larrain, S; Rinella, ME1
Adachi, N; Fujita, N; Goto, H; Hasegawa, D; Hirota, Y; Inukai, T; Ishida, H; Kanegane, H; Kato, K; Kigasawa, H; Kikuchi, A; Kikuta, A; Kishimoto, T; Kobayashi, M; Koike, K; Kuroda, H; Matsuzaki, A; Nagatoshi, Y; Nakamura, K; Nakano, T; Nakazawa, Y; Okada, K; Osugi, Y; Tanaka, R; Tokuda, K; Tsuchida, M; Uoshima, N; Watanabe, A; Yabe, H; Yagasaki, H; Yoshihara, T1
Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D1

Reviews

1 review(s) available for methotrexate and Genetic Diseases

ArticleYear
A myriad of pathways to NASH.
    Clinics in liver disease, 2012, Volume: 16, Issue:3

    Topics: Amiodarone; Anti-Retroviral Agents; Bacterial Infections; Cannabis; Diet; Fatty Liver; Genetic Diseases, Inborn; Glucocorticoids; Humans; Hypothyroidism; Insulin Resistance; Intestinal Diseases; Lipid Metabolism; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Occupational Diseases; Perhexiline

2012

Other Studies

2 other study(ies) available for methotrexate and Genetic Diseases

ArticleYear
Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents.
    International journal of hematology, 2007, Volume: 85, Issue:3

    Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chimerism; Drug Therapy, Combination; Genetic Diseases, Inborn; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome

2007
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin

1996